Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression

scientific article published on 01 February 1995

Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0006-3223(94)00174-2
P698PubMed publication ID7727623

P50authorPhilip B. MitchellQ37393406
Marie-Paule AustinQ43279405
P2093author name stringScott E
Wilhelm K
Bennett B
Hickie I
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectpatientQ181600
P304page(s)151-160
P577publication date1995-02-01
P1433published inBiological PsychiatryQ4914961
P1476titleSubcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression
P478volume37

Reverse relations

cites work (P2860)
Q52017096"Side effects" of ECT are mainly depressive phenomena and are independent of age.
Q4604286531Phosphorus magnetic resonance spectroscopy study of tissue specific changes in high energy phosphates before and after sertraline treatment of geriatric depression
Q731540733D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity
Q37458500A model for intervention research in late-life depression
Q48641104A preliminary profile of neuropsychological deficits associated with major depression.
Q52024828A prospective follow-up study of ECT outcome in older depressed patients.
Q37082587A review of etiologies of depression in COPD.
Q48458709A unifying hypothesis of Alzheimer's disease. III. Risk factors.
Q33599288Accelerated aging of the putamen in patients with major depressive disorder
Q36261418Aging and clinical pharmacology: implications for antidepressants
Q36955633Alterations of white matter integrity in adults with major depressive disorder: a magnetic resonance imaging study
Q35188783Amygdala volume in late-life depression: relationship with age of onset
Q90368732An Electrophysiological Biomarker That May Predict Treatment Response to ECT
Q48516406Anatomic location and laterality of MRI signal hyperintensities in late-life depression.
Q48913237Anatomical MRI study of basal ganglia in bipolar disorder patients.
Q34532241Annual research review: progress in using brain morphometry as a clinical tool for diagnosing psychiatric disorders
Q31135283Anterior cingulate dysfunction in geriatric depression
Q26798235Applications of magnetic resonance imaging for treatment-resistant late-life depression
Q33570573Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in mice
Q34259252Biological basis of late life depression
Q30799242Biological predictors of treatment response in affective illness
Q31153979Biomarkers of cerebrovascular disease in dementia.
Q33442474Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide
Q89941156Blood glutamate scavenging as a novel glutamate-based therapeutic approach for post-stroke depression
Q87932898Brain structural connectivity in late-life major depressive disorder
Q33884764Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression: a randomized, placebo-controlled study
Q48243726Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression
Q33924958Cerebrovascular disease and late life depression: an age old association revisited
Q36645259Cerebrovascular disease basis of depression: post-stroke depression and vascular depression.
Q39934258Characteristics of neurocognitive functions in mild cognitive impairment with depression
Q37378965Citalopram for continuation therapy after repetitive transcranial magnetic stimulation in vascular depression
Q34721893Clinical classification in mental health at the cross-roads: which direction next?
Q48458736Clinical impacts of single transcranial magnetic stimulation (sTMS) as an add-on therapy in severely depressed patients under SSRI treatment.
Q36546373Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions
Q34934354Comorbidity of late life depression: an opportunity for research on mechanisms and treatment
Q34851711Complexity in late-life depression: impact of confounding factors on diagnosis, treatment, and outcomes
Q48355056Deep white matter hyperintensities in patients with bipolar depression, unipolar depression and age-matched control subjects.
Q36728889Defining melancholia: the primacy of psychomotor disturbance.
Q74098529Depression in later life: three etiologically different subgroups
Q34423873Depression in the elderly
Q48084888Depression, vascular factors, and risk of dementia in primary care: a retrospective cohort study
Q34991066Diabetes, the brain, and behavior: is there a biological mechanism underlying the association between diabetes and depression?
Q34392959Different associations of white matter lesions with depression and cognition
Q35155918Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders
Q31034460Diffusion-weighted magnetic resonance imaging of white matter in bipolar disorder: a pilot study
Q22299260Distinguishing Between Depression and Dementia in Older Persons: Neuropsychological and Neuropathological Correlates
Q58295280Do depressive symptoms in memory-impaired elders predict probable Alzheimer's disease?
Q57268913Do the Genetic or Environmental Determinants of Anxiety and Depression Change with Age? A Longitudinal Study of Australian Twins
Q48538804Does neuroanatomy predict ECT response?
Q49137375ECT stimulus dosing techniques.
Q43751929Early and late onset depression in old age: different aetiologies, same phenomenology
Q33964983Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis
Q24248680Electroconvulsive therapy for the depressed elderly
Q31391381Elevated sorbitol concentration in the cerebrospinal fluid of patients with mood disorders
Q34013538Epidemiology and treatment of post-stroke depression.
Q52543727Evidence of white matter tract disruption in MRI hyperintensities.
Q45039027Executive dysfunction, heart disease burden, and remission of geriatric depression
Q48068307Factors related to prevalence, persistence, and incidence of depressive symptoms in mild cognitive impairment: vascular depression construct
Q21144232Frontal white matter anisotropy and antidepressant remission in late-life depression
Q48306996Frontostriatal deficits in unipolar major depression.
Q34641123Geriatric depression and cognitive impairment
Q36951926Getting better, getting well: understanding and managing partial and non-response to pharmacological treatment of non-psychotic major depression in old age.
Q90049422How well do elderly patients with major depressive disorder respond to antidepressants: a systematic review and single-group meta-analysis
Q33550545Hyperintense MRI lesions in bipolar disorder: A meta-analysis and review
Q30478592Imaging phenotypes of major depressive disorder: genetic correlates
Q48859931Increased prevalence of white matter hyperintensities in patients with panic disorder.
Q30742791Is late onset depression a prodrome to dementia?
Q35111565Is treatment-resistant depression a unique subtype of depression?
Q79761773Late onset dysthymic disorder and major depression differ from early onset dysthymic disorder and major depression in elderly outpatients
Q36199216Late-life depression: a model for medical classification.
Q52995654Late-life depression: the differences between early- and late-onset illness in a community-based sample.
Q35692848Late-life mood disorders
Q46602365Late-onset major depression: clinical and treatment-response variability
Q54513349Lobar distribution of lesion volumes in late-life depression: the Biomedical Informatics Research Network (BIRN).
Q48414813Localization of white-matter lesions and effect of vascular risk factors in late-onset major depression.
Q34439133MRI findings in patients with affective disorder: a meta-analysis
Q34160970MRI signal hyperintensities and treatment remission of geriatric depression
Q44205654MRI subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression
Q43827146MRI white matter hyperintensities, (1)H-MR spectroscopy and cognitive function in geriatric depression: a comparison of early- and late-onset cases
Q37824646MRI-defined vascular depression: a review of the construct
Q30724972Magnetic resonance imaging predictors of treatment response in late-life depression
Q34747376Models of care for late-life depression of the medically ill: examples from chronic obstructive pulmonary disease and stroke
Q30585266Neuroanatomic substrates of late-life mental disorders
Q35482688Neuroanatomical localisation and clinical correlates of white matter lesions in the elderly
Q37293670Neurocognitive correlates of response to treatment in late-life depression
Q51893179Neurocognitive profiles in older adults with and without major depression.
Q42379926Neuroimaging in geriatric psychiatry: integrative research as the next frontier
Q31073705Neuroimaging in late-life depression
Q30815738Neuroimaging studies of mood disorder effects on the brain
Q34489109Neuropsychiatry of the basal ganglia
Q38477042Outcomes focused service delivery: developing an academic-management partnership
Q99585323Oxygenation differs among white matter hyperintensities, intersected fiber tracts and unaffected white matter
Q33857662Pathways linking late-life depression to persistent cognitive impairment and dementia.
Q42167218Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine
Q33832945Persistent depressive symptoms after acute coronary syndrome are associated with compromised white matter integrity in the anterior cingulate: a pilot study
Q34739679Problem solving therapy for the depression-executive dysfunction syndrome of late life
Q40368213Prognosis of late life depression: a three-year cohort study of outcome and potential predictors
Q46989145Progression of cerebral white matter lesions is not associated with development of depressive symptoms in elderly subjects at risk of cardiovascular disease: The PROSPER Study
Q81569030Prospective study of major depressive disorder with white matter hyperintensity: comparison of patients with and without lacunar infarction
Q47762925Psychiatric event in multiple sclerosis: could it be the tip of the iceberg?
Q26822727Psychomotor retardation in depression: a systematic review of diagnostic, pathophysiologic, and therapeutic implications
Q24629825Psychomotor retardation in depression: biological underpinnings, measurement, and treatment
Q47925432Psychosocial and vascular risk factors of depression in later life
Q48714695Quantitative evaluation of magnetic resonance imaging of deep white matter hyperintensity in geriatric patients by multifractal analysis.
Q35014333Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study
Q36885496Recent advances in neuroimaging biomarkers in geriatric psychiatry
Q37374497Reductions in neuronal density in elderly depressed are region specific
Q48868418Regional cerebral volume measurements in late-life depression: relationship to clinical correlates, neuropsychological impairment and response to treatment.
Q35236806Regulation of cellular plasticity and resilience by mood stabilizers: the role of AMPA receptor trafficking
Q37120121Relationship of cerebrospinal fluid glucose metabolites to MRI deep white matter hyperintensities and treatment resistance in bipolar disorder patients
Q48763940Relationship of endothelial function and atherosclerosis to treatment response in late-life depression.
Q48379900Relevance of brain imaging studies for social psychiatry.
Q34067137SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment.
Q44993156Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55-75 years of age: a pilot study
Q34479180Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression
Q45721523Sensitivity of cognitive tests in four cognitive domains in discriminating MDD patients from healthy controls: a meta-analysis
Q73196400Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging
Q33844090Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study
Q33933220Soluble amyloid-β levels and late-life depression
Q26765315Strategies to improve anxiety and depression in patients with COPD: a mental health perspective
Q35226749Striatal Hypodensities, Not White Matter Hypodensities on CT, Are Associated with Late-Onset Depression in Alzheimer's Disease
Q48438470Structural and functional abnormalities in elderly patients clinically recovered from early- and late-onset depression.
Q80249687Structural changes in the brain in depression and relationship to symptom recurrence
Q32127061Structural changes in the brain of patients with bipolar affective disorder by MRI: a review of the literature
Q32062412Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions
Q42420329Structural neuroimaging research methods in geriatric depression
Q30769395Structural neuroimaging studies in late-life depression: a review
Q48632288Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression--a longitudinal evaluation.
Q48213622Subcortical lesion severity and orbitofrontal cortex volume in geriatric depression
Q36902306Subcortical vascular disease in elderly patients with treatment resistant depression
Q33948757Subjective memory complaints, vascular risk factors and psychological distress in the middle-aged: a cross-sectional study
Q33726069Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial
Q34299420The Significance of Cerebral White Matter Abnormalities 100 Years After Binswanger’s Report
Q34412882The anatomy of mood disorders--review of structural neuroimaging studies
Q40523434The cerebrovascular model of depression in late life
Q37792994The depression-executive dysfunction (DED) syndrome and response to antidepressants: a meta-analytic review.
Q48288063The differentiation of DSM-III-R psychotic depression in later life from nonpsychotic depression: comparisons of brain changes measured by multispectral analysis of magnetic resonance brain images, neuropsychological findings, and clinical features
Q35553727The efficacy and safety of ECT in depressed older adults: a literature review
Q48508468The external validity of MRI-defined vascular depression.
Q38389929The functional anatomy of psychomotor disturbances in major depressive disorder
Q59100449The neurobiological pathogenesis of poststroke depression
Q30656863The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review
Q30582097The pathomorphology of schizophrenia and mood disorders: similarities and differences
Q49025075The prognostic significance of abnormalities seen on magnetic resonance imaging in late life depression: clinical outcome, mortality and progression to dementia at three years.
Q55163955The role of neuroinflammation and neurovascular dysfunction in major depressive disorder.
Q34824971The vascular depression hypothesis: an update
Q27010321The vascular depression hypothesis: mechanisms linking vascular disease with depression
Q37004131The vascular depression subtype: evidence of internal validity
Q34267093Three-dimensional surface mapping of the caudate nucleus in late-life depression
Q35795147Time course of response to antidepressants in late-life major depression: therapeutic implications
Q48530007Top cited papers in international psychogeriatrics: 5. A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly.
Q36747232Translational research in late-life mood disorders: implications for future intervention and prevention research
Q34112222Treatment of late-life depression: a role of non-invasive brain stimulation techniques
Q32067550Treatment resistant depression in the elderly: a review of its conceptualisation, management and relationship to organic brain disease
Q28290605Treatment-resistant depression: critique of current approaches
Q41409960Utilising molecular biological and histopathological techniques to study the dopaminergic system in patients with melancholia
Q31110410Validity of vascular depression as a specific diagnostic: a review
Q30912417Value of diagnostic imaging in evaluation of electroconvulsive therapy
Q57056107Vascular depression and the death of Queen Victoria
Q42623204Vascular depression: overrepresented among African Americans?
Q47843010Vascular risk factors in older patients with depression: outcome of electroconvulsive therapy versus medication.
Q51951093Vascular risk to late-life depression: evidence from a longitudinal community study.
Q64075368Volumetric Reductions of Subcortical Structures and Their Localizations in Alcohol-Dependent Patients
Q36798672White matter hyperintensities: from medical comorbidities to bipolar disorders and back
Q52931288[Post-stroke depression: clinical aspects, epidemiology, therapy, and pathophysiology].
Q79932722[Vascular depression: important and limited issues of the concept]

Search more.